What's new

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Apr 24, 2025 - 11:07
 0
Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Etiome, a new Flagship startup, looks to catch disease before it strikes

Next Article

Meyer Burger shifts to ‘short-time work’ at Thalheim cell facility

Related Posts

Cancer Medicines Forum: December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 December 2024, 13:00 (CET) to 16 December 2024, 15:00 (CET)

Cancer Medicines Forum: December 2024, Online, European...

Mar 11, 2025  0

Herbal medicinal product: Sambuci flos, Sambucus nigra L., C: ongoing call for scientific data

Herbal medicinal product: Sambuci flos, Sambucus nigra ...

Mar 13, 2025  0

Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive

Orphan designation: Rilzabrutinib Treatment of autoimmu...

Feb 20, 2025  0